Switch theme
Sign up to access all valuation multiples
Kao is the largest household and personal care product manufacturer in Japan with a footprint across Asia, Europe, and the Americas. Japan remains its largest market, contributing about 50% of sales and operating profits with several leading brands including Attack and Biore. Initially a soap producer established in the 1890s, Kao has expanded into cosmetics, disposable hygiene products, and chemicals, in addition to its homecare and toiletry products. Asia, the largest overseas market contributes around 15% of group sales. Kao has also acquired several Western skin and haircare brands including Jergens, John Frieda, Curel, Molton Brown, and the latest, Oribe.
1940
46.3K+
LTM Revenue $11.3B
LTM EBITDA $1.7B
$20.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Kao has a last 12-month revenue (LTM) of $11.3B and a last 12-month EBITDA of $1.7B.
In the most recent fiscal year, Kao achieved revenue of $11.2B and an EBITDA of $1.7B.
Kao expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Kao valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $11.3B | XXX | $11.2B | XXX | XXX | XXX |
| Gross Profit | $4.7B | XXX | $4.4B | XXX | XXX | XXX |
| Gross Margin | 42% | XXX | 39% | XXX | XXX | XXX |
| EBITDA | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBIT | $1.1B | XXX | $1.0B | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $781M | XXX | $740M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Kao's stock price is JPY 6606 (or $45).
Kao has current market cap of JPY 3.07T (or $21.1B), and EV of JPY 3.03T (or $20.8B).
See Kao trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20.8B | $21.1B | XXX | XXX | XXX | XXX | $1.68 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Kao has market cap of $21.1B and EV of $20.8B.
Kao's trades at 1.9x EV/Revenue multiple, and 12.4x EV/EBITDA.
Equity research analysts estimate Kao's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Kao has a P/E ratio of 27.0x.
See valuation multiples for Kao and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $21.1B | XXX | $21.1B | XXX | XXX | XXX |
| EV (current) | $20.8B | XXX | $20.8B | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 12.5x | XXX | 12.4x | XXX | XXX | XXX |
| EV/EBIT | 19.6x | XXX | 20.6x | XXX | XXX | XXX |
| EV/Gross Profit | 4.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 27.0x | XXX | 28.5x | XXX | XXX | XXX |
| EV/FCF | 24.8x | XXX | 22.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialKao's last 12 month revenue growth is 3%
Kao's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Kao's rule of 40 is 13% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kao's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Kao and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 27% | XXX | XXX | XXX |
| Rule of 40 | 13% | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kao acquired XXX companies to date.
Last acquisition by Kao was XXXXXXXX, XXXXX XXXXX XXXXXX . Kao acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Kao founded? | Kao was founded in 1940. |
| Where is Kao headquartered? | Kao is headquartered in Japan. |
| How many employees does Kao have? | As of today, Kao has 46.3K+ employees. |
| Who is the CEO of Kao? | Kao's CEO is Mr. Yoshihiro Hasebe. |
| Is Kao publicy listed? | Yes, Kao is a public company listed on TKS. |
| What is the stock symbol of Kao? | Kao trades under 4452 ticker. |
| When did Kao go public? | Kao went public in 1949. |
| Who are competitors of Kao? | Similar companies to Kao include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Kao? | Kao's current market cap is $21.1B |
| What is the current revenue of Kao? | Kao's last 12 months revenue is $11.3B. |
| What is the current revenue growth of Kao? | Kao revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Kao? | Current revenue multiple of Kao is 1.8x. |
| Is Kao profitable? | Yes, Kao is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Kao? | Kao's last 12 months EBITDA is $1.7B. |
| What is Kao's EBITDA margin? | Kao's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Kao? | Current EBITDA multiple of Kao is 12.5x. |
| What is the current FCF of Kao? | Kao's last 12 months FCF is $839M. |
| What is Kao's FCF margin? | Kao's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Kao? | Current FCF multiple of Kao is 24.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
